BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets. MZ will work closely with BioHarvest management to develop and implement a comprehensive capital markets...
2024-02-15 8:31 AM EST
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a pioneer in Botanical Synthesis technology that grows Phyto-active compositions without growing the plant, announces its upcoming participation and sponsorship of the 2024 BIO CEO & Investor Conference, which will take place in New York City from February 26-27, 2024. Ilan Sobel, Chief Executive Officer of BioHarvest, is...
2024-02-12 8:30 AM EST
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a pioneer in Botanical Synthesis technology that grows active Phyto-nutrient compositions without growing the plant, has issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholder Partners, 2023 marked a pivotal year for BioHarvest, highlighted by robust revenue growth, gross...
2024-01-08 8:00 AM EST
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the second and final tranche of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 19 and October 20, 2023. In this tranche closed Friday December 22, 2023, the Company reported that it had issued Notes in the aggregate principal...
2023-12-27 8:00 AM EST
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 13, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has created a new "functional" coffee product line featuring VINIA® Red Grape Superfood, its flagship nutraceutical product. Tens of thousands of subscribers take VINIA® daily to improve blood flow, which enhances their physical energy and m
2023-12-13 8:00 AM EST
BioHarvest Sciences to Host Virtual Shareholder Update December 13, 2023, 2:30pm ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 1, 2023) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) announces that it is hosting the Q3 Performance Update Presentation on Wednesday, December 13, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by Ilan Sobel, CEO of BioHarvest Sciences. "I am currently in Nashville, Tennessee, as part of a U.S. media and operational partner tour ahead of the imminent launch...
2023-12-01 2:22 PM EST
BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 29, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q3 2023 results. Q3 2023 revenue of its flagship VINIA® product reached USD 3.24M which is well within the projected range and represents 113% growth c
2023-11-29 8:00 AM EST
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 19 and October 20, 2023. The Company has issued Notes in the aggregate principal amount of CA$ 11,786,489.90, in this first tranche of an announced financing of...
2023-10-30 8:00 AM EDT
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 10, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that VINIA®, its flagship nutraceutical product derived from red grape cells, has received its Canadian product license from Health Canada's Natural and Non-Prescription Health Products Directorate. This Product License authorizes BioHarvest Sciences to sell VINIA
2023-10-10 11:55 AM EDT
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 6, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that US sales of its flagship product VINIA® in the month of August have crossed the USD 1Million per month line. This significant milestone marks a new inflection point in BioHarvest's journey and offers further validation of its Botanical Synthesis technology platform. This milestone also demonstrates the power...
2023-09-06 8:00 AM EDT
BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 30, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q2 2023 results. Revenue of its flagship VINIA® product reached USD 2.75M, representing 228% growth compared to the same quarter of last year and 27% growth compared to Q1 2
2023-08-30 8:00 AM EDT
BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 24, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") announces that it is hosting the Q2 Performance Update Presentation on Wednesday, September 6, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by CEO Ilan Sobel. Mr. Sobel will discuss the Q2 financials announced this coming August 30th, and he will provide additional information regarding major VINIA...
2023-08-24 8:40 AM EDT
BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 18, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed its non-brokered private placement of convertible notes (the "Notes") previously announced on July 7, 2023. The Company has issued Notes in the aggregate principal amount of CA$4,642,075.50. The Company has paid finder's fees of $41,282.20 to a finder on a portion of the private...
2023-07-18 8:00 AM EDT
BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2023) - Dr. Brian Cornblatt, the Chief Medical Officer of BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHarvest" or "the company"), delivered a keynote address on the "HealthConf" stage at the Collision conference in Toronto on Thursday. Dr. Cornblatt opened up for the first time about his medical misdiagnosis for Multiple Sclerosis, as well as various cancer experiences by friends and family, which compelled him...
2023-06-30 8:27 AM EDT
BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has been invited to one of the largest and fastest-growing technology conferences in North America. Its Chief Medical Officer, Dr. Brian Cornblatt, will deliver the keynote speech on the "HealthConf" stage at Collision on Thursday, June 29th at 10:45 am EST. After his keynote address, Dr. Cornblatt will host the stage...
2023-06-27 8:00 AM EDT
BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it will be participating in the Jefferies Vitamins and Supplements Conference, June 27, in London, England. BioHarvest Sciences CEO Ilan Sobel will be attending this prestigious industry conference as an invited speaker, and he will be included in a panel titled "Growing Impact of Emerging and Disruptive Brands."...
2023-06-26 9:21 AM EDT
BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") has unveiled a plan to enter new consumption categories where VINIA will be incorporated to create unique and highly differentiated products for the Food & Beverage and the Nutraceuticals markets. VINIA's success in the first two years since its 2021 US launch is not only celebratory in terms of significant reve
2023-06-21 8:00 AM EDT
BioHarvest Sciences Adds Renowned Scientist to Scientific Advisory Board
Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that it has added Dr. John Paul SanGiovanni, world renowned nutritionist and Harvard-trained scientist, to its Medical and Scientific Advisory board. Dr. SanGiovanni will act as a liaison with the spheres of Academia, Industry, and Government, helping spread the promise and potential of Botanical Synthesis. His deep connections within Academic and research institutions will introduce...
2023-06-06 8:00 AM EDT
BioHarvest Reports Q1 2023 Results Demonstrating Strong Year Over Year Growth
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 31, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q1 2023 results. Revenue of its flagship VINIA® product reach
2023-05-31 7:30 AM EDT
BioHarvest Adds over 25,000 US Customers in Last 365 Days and Congratulates NFL "Team VINIA" Prospects on Draft Day Success
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 4, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) has surpassed 2,000 verified online reviews for its flagship product, VINIA, following the launch of the first major 2023 marketing campaign, "Real Stories," focusing on the red grape-based supplement's impact on customers' lives. "Our online reviews do more than give new customers the confidence to try VINIA," said Dr. Brian Cornblatt, Chief Medical Officer. "The
2023-05-04 8:00 AM EDT